Celularity Valuation
| CELU Stock | USD 3.03 0.83 37.73% |
At this time, the firm appears to be overvalued. Celularity shows a prevailing Real Value of $2.38 per share. The current price of the firm is $3.03. Our model approximates the value of Celularity from analyzing the firm fundamentals such as Profit Margin of (1.07) %, return on equity of -2.33, and Current Valuation of 127.49 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Celularity's price fluctuation is dangerous at this time. Calculation of the real value of Celularity is based on 3 months time horizon. Increasing Celularity's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Celularity's intrinsic value may or may not be the same as its current market price of 3.03, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.03 | Real 2.38 | Hype 3.23 | Naive 2.93 |
The intrinsic value of Celularity's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Celularity's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Celularity helps investors to forecast how Celularity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Celularity more accurately as focusing exclusively on Celularity's fundamentals will not take into account other important factors: Celularity Total Value Analysis
Celularity is currently expected to have valuation of 127.49 M with market capitalization of 72.57 M, debt of 29.03 M, and cash on hands of 42.65 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Celularity fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
127.49 M | 72.57 M | 29.03 M | 42.65 M |
Celularity Investor Information
About 51.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.64. Celularity had not issued any dividends in recent years. The entity had 1:10 split on the 29th of February 2024. Based on the key measurements obtained from Celularity's financial statements, Celularity is not in a good financial situation at this time. It has a very high odds of going through financial crisis in August.Celularity Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Celularity has an asset utilization ratio of 40.86 percent. This implies that the Company is making $0.41 for each dollar of assets. An increasing asset utilization means that Celularity is more efficient with each dollar of assets it utilizes for everyday operations.Celularity Ownership Allocation
Celularity holds a total of 23.95 Million outstanding shares. Celularity retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Celularity Profitability Analysis
The company reported the previous year's revenue of 54.22 M. Net Loss for the year was (57.89 M) with profit before overhead, payroll, taxes, and interest of 39.23 M.About Celularity Valuation
The stock valuation mechanism determines Celularity's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Celularity based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Celularity. We calculate exposure to Celularity's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Celularity's related companies.Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey. Celularity operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 225 people.
Celularity Growth Indicators
Investing in growth stocks can be very risky. If the company such as Celularity does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 21.9 M | |
| Quarterly Earnings Growth Y O Y | -0.613 |
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.